[PRLD] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
16-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -14.86%
YoY- -91.75%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -30,687 -26,865 -21,300 -19,250 -16,760 -11,408 -9,511 118.19%
Tax -356 -290 -282 0 0 0 0 -
NP -30,687 -26,865 -21,300 -19,250 -16,760 -11,408 -9,511 118.19%
Tax Rate - - - - - - - -
Total Cost 30,687 26,865 21,300 19,250 16,760 11,408 9,511 118.19%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.66 -0.58 -0.47 -0.51 -0.44 -0.30 -0.29 72.93%
EPS Diluted -0.66 -0.58 -0.47 -0.51 -0.44 -0.30 -0.29 72.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.